13F
中

ABBV ABBVIE INC

2026Q1 · CUSIP 00287Y109 · Big Pharma · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
4,029
Δ holders QoQ
-61
Breadth percentile
Top 98%
Whale holders
359
Δ whales
-1
Inst. holding value
$268.4B
New positions
204
Closed positions
265
Price momentum (1Q)
-9.3%
Put / Call
51/50

Breadth history (34 quarters)

2018Q1: Δ+21 · h=1909 2018Q2: Δ-25 · h=1884 2018Q3: Δ-32 · h=1852 2018Q4: Δ+101 · h=1953 2019Q1: Δ-23 · h=1930 2019Q2: Δ-10 · h=1920 2019Q3: Δ-5 · h=1915 2019Q4: Δ+228 · h=2143 2020Q1: Δ-11 · h=2132 2020Q2: Δ+179 · h=2311 2020Q3: Δ-39 · h=2272 2020Q4: Δ+228 · h=2500 2021Q1: Δ+11 · h=2511 2021Q2: Δ+62 · h=2573 2021Q3: Δ-14 · h=2559 2021Q4: Δ+332 · h=2891 2022Q1: Δ+59 · h=2950 2022Q2: Δ-26 · h=2924 2022Q3: Δ-38 · h=2886 2022Q4: Δ+199 · h=3085 2023Q1: Δ-19 · h=3066 2023Q2: Δ-61 · h=3005 2023Q3: Δ+36 · h=3041 2023Q4: Δ+215 · h=3256 2024Q1: Δ+52 · h=3308 2024Q2: Δ-7 · h=3301 2024Q3: Δ+131 · h=3432 2024Q4: Δ+249 · h=3681 2025Q1: Δ+69 · h=3750 2025Q2: Δ-34 · h=3716 2025Q3: Δ+126 · h=3842 2025Q4: Δ+248 · h=4090 2026Q1: Δ-61 · h=4029 2018Q1: holders=1909 2018Q2: holders=1884 2018Q3: holders=1852 2018Q4: holders=1953 2019Q1: holders=1930 2019Q2: holders=1920 2019Q3: holders=1915 2019Q4: holders=2143 2020Q1: holders=2132 2020Q2: holders=2311 2020Q3: holders=2272 2020Q4: holders=2500 2021Q1: holders=2511 2021Q2: holders=2573 2021Q3: holders=2559 2021Q4: holders=2891 2022Q1: holders=2950 2022Q2: holders=2924 2022Q3: holders=2886 2022Q4: holders=3085 2023Q1: holders=3066 2023Q2: holders=3005 2023Q3: holders=3041 2023Q4: holders=3256 2024Q1: holders=3308 2024Q2: holders=3301 2024Q3: holders=3432 2024Q4: holders=3681 2025Q1: holders=3750 2025Q2: holders=3716 2025Q3: holders=3842 2025Q4: holders=4090 2026Q1: holders=4029 -332 -166 +0 +166 +332 166629814295 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 17 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 1% -9.3% —
2025Q3 Top 1% -3.4% -7.8%
2025Q1 Top 1% +12.0% +28.0%
2024Q4 Top 1% -4.5% +7.0%
2024Q3 Top 0% +22.7% +11.8%
2024Q1 Top 4% +19.4% +0.9%
2023Q4 Top 1% -5.4% +13.0%
2023Q3 Top 3% +28.3% +21.3%

Options Sentiment

Put holders
51
QoQ: +3
Call holders
50
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
120.8
EPS (TTM)
$2.03
EPS YoY
-13.6%
Revenue (TTM)
$62.8B
Revenue YoY
+9.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $14.6B 2022-09-30: $14.8B 2022-12-31: $15.1B 2023-03-31: $12.2B 2023-06-30: $13.9B 2023-09-30: $13.9B 2023-12-31: $14.3B 2024-03-31: $12.3B 2024-06-30: $14.5B 2024-09-30: $14.5B 2024-12-31: $15.1B 2025-03-31: $13.3B 2025-06-30: $15.4B 2025-09-30: $15.8B 2025-12-31: $16.6B 2026-03-31: $15.0B 2022-06-30: EPS 0.51 2022-09-30: EPS 2.21 2022-12-31: EPS 1.38 2023-03-31: EPS 0.13 2023-06-30: EPS 1.14 2023-09-30: EPS 1.00 2023-12-31: EPS 0.46 2024-03-31: EPS 0.77 2024-06-30: EPS 0.77 2024-09-30: EPS 0.88 2024-12-31: EPS -0.02 2025-03-31: EPS 0.72 2025-06-30: EPS 0.52 2025-09-30: EPS 0.10 2025-12-31: EPS 1.02 2026-03-31: EPS 0.39 0B 8.3B 16.6B $B -0.02 1.20 2.43 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 61 2023-03-31: PE 30.42023-06-30: PE 28.32023-09-30: PE 34.72023-12-31: PE 60.22024-03-31: PE 46.12024-06-30: PE 612024-09-30: PE 54.52024-12-31: PE 77.12025-03-31: PE 75.82025-06-30: PE 96.12025-09-30: PE 173.22025-12-31: PE 97.32026-03-31: PE 103.6 25 104 182 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)